Tag

Tag: Argenx

argenx myasthenia gravis efgartigimod

29/05/2020 2 mins

Argenx Follows up Phase III Success with Giant €785M Global Offering

argenx antibody efgartigimod myastenia gravis

26/05/2020 2 mins

Argenx’s Rare Disease Treatment Strikes Gold in Phase III

argenx blood cancer autoimmune disease

11/11/2019 1 min

Argenx Raises Whopping €502M in Global Offering

argenx regenerative medicine agomAb llama-inspired antibodies

03/04/2019 2 mins

€21M Series A to Finance Belgian Biotech’s Regenerative Antibodies

argenx llama-inspired antibodies cover cancer immunotherapy

05/12/2018 2 mins

Llama-Inspired Antibodies Succeed in Clinical Trials and Financial Deal

29/10/2018 6 mins

The Billion-Euro European Biotech Companies in 2018

Argenx story - antibody drugs & fundraiser

19/09/2018 1 min

Argenx Attracts Huge €250M Investment Following Positive Phase II Trial

14/12/2017 1 min

Belgian Biotech Raises $231M to Continue Developing its Antibody Therapies

11/12/2017 1 min

Belgian Antibody Proves Effective to Treat Myasthenia Gravis

23/08/2017 1 min

Dutch Biotech could treat Dyslipidemia with Belgian Nanobody

argenx blood cancer autoimmune disease

20/06/2017 1 min

Belgian Llama Antibody Developer gets Second Preclinical Milestone from Danish Pharma

22/05/2017 <1 min

UPDATE: Argenx’s IPO soars to over €100M to prove itself in Phase II